Hyperthyroidism: Pathology review

Last updated: November 01, 2022

Hyperthyroidism: Pathology review

Watch later

Watch later

Nernst equation
Cytoskeleton and intracellular motility
Cell signaling pathways
Resting membrane potential
Gene regulation
Epigenetics
Nuclear structure
DNA structure
Transcription of DNA
Amino acids and protein folding
Necrosis and apoptosis
Endometrial hyperplasia and cancer: Clinical
Lung cancer and mesothelioma: Pathology review
Metaplasia and dysplasia
Oral cancer
Testicular cancer
Lung cancer
Asthma
Atrial septal defect
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Acute respiratory distress syndrome
Angina pectoris
Aortic valve disease
Bronchiectasis
Chronic bronchitis
Chronic venous insufficiency
Coarctation of the aorta
Deep vein thrombosis
Emphysema
Endocarditis
Gas exchange in the lungs, blood and tissues
Heart failure
Mitral valve disease
Cor pulmonale
Heart failure: Pathology review
Myocarditis
Diabetes mellitus: Pathology review
Adrenocorticotropic hormone
Chlamydia trachomatis
Cortisol
Abnormal uterine bleeding: Clinical
Cushing syndrome
Endometriosis
Glucagon
Glucocorticoids
Herpes simplex virus
HIV (AIDS)
Hypothyroidism: Pathology review
Hypothyroidism
Insulin
Neisseria gonorrhoeae
Pelvic inflammatory disease
Polycystic ovary syndrome
Benign prostatic hyperplasia
Thyroid hormones
Testosterone
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Primary adrenal insufficiency
Hyperthyroidism: Pathology review
Chronic leukemia
Anemia of chronic disease
Hemophilia
Heparin-induced thrombocytopenia
Hypocalcemia
Hypermagnesemia
Hypokalemia
Hypomagnesemia
Inflammation
Innate immune system
Complement system
Iron deficiency anemia
Leukemias: Pathology review
Platelet disorders: Pathology review
Sickle cell disease (NORD)
Type IV hypersensitivity
Vaccinations
Acute pyelonephritis
Celiac disease
Cirrhosis
Congenital disorders: Clinical
Appendicitis
Autoimmune hepatitis
Bowel obstruction
Chronic cholecystitis
Chronic pyelonephritis
Crohn disease
Gastroesophageal reflux disease (GERD)
Nephrotic syndromes: Pathology review
Irritable bowel syndrome
Lower urinary tract infection
Biliary colic
Peptic ulcer
Renal failure: Pathology review
Urinary tract infections: Pathology review
Viral hepatitis
Pancreatitis: Pathology review
Alcohol-associated liver disease
Ulcerative colitis
Medullary cystic kidney disease
Small bowel ischemia and infarction
Chronic kidney disease
Acute cholecystitis
Skin cancer
Autosomal trisomies: Pathology review
Selective permeability of the cell membrane
Free radicals and cellular injury
Pericarditis and pericardial effusion
Peripheral artery disease
Cauda equina syndrome
Cranial nerves
Dementia: Pathology review
Arteriovenous malformation
Bipolar and related disorders
Seizures and epilepsy
Generalized anxiety disorder
Headaches: Pathology review
Huntington disease
Ischemic stroke
Major depressive disorder
Meningitis
Migraine
Multiple sclerosis
Myasthenia gravis
Panic disorder
Parkinson disease
Alzheimer disease
Approach to abnormal uterine bleeding in reproductive-aged patients: Clinical sciences
Coagulation disorders: Pathology review
Factor V Leiden
Hodgkin lymphoma
Disseminated intravascular coagulation
Non-Hodgkin lymphoma
Introduction to the immune system
Acute pancreatitis
Approach to congenital heart diseases (acyanotic): Clinical sciences
Acne vulgaris
Atopic dermatitis
Back pain: Pathology review
Bone disorders: Pathology review
Burns
Osteoarthritis
Osteoporosis
Paget disease of bone
Psoriasis
Rheumatoid arthritis
Varicella zoster virus
Introduction to pharmacology
Drug administration and dosing regimens
Enzyme function
Pharmacokinetics: Drug metabolism
Pharmacokinetics: Drug elimination and clearance
Pharmacokinetics: Drug absorption and distribution
Pharmacodynamics: Drug-receptor interactions
Pharmacodynamics: Desensitization and tolerance
Pharmacodynamics: Agonist, partial agonist and antagonist
Opioid agonists, mixed agonist-antagonists and partial agonists
Opioid use disorder
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Opioid antagonists
Anticoagulants: Direct factor inhibitors
Anticoagulants: Heparin
Anticoagulants: Warfarin
Antiplatelet medications
Thrombolytics
Hematopoietic medications
Role of Vitamin K in coagulation
Loop diuretics
Miscellaneous lipid-lowering medications
Potassium sparing diuretics
Adrenergic antagonists: Alpha blockers
Calcium channel blockers
Adrenergic antagonists: Beta blockers
Lipid-lowering medications: Statins
Lipid-lowering medications: Fibrates
Class II antiarrhythmics: Beta blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Class I antiarrhythmics: Sodium channel blockers
Thiazide and thiazide-like diuretics
ACE inhibitors, ARBs and direct renin inhibitors
Positive inotropic medications
Anti-mite and louse medications
Antimalarials
Hepatitis medications
Anthelmintic medications
Integrase and entry inhibitors
Antimetabolites: Sulfonamides and trimethoprim
Azoles
Cell wall synthesis inhibitors: Cephalosporins
Cell wall synthesis inhibitors: Penicillins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Echinocandins
Herpesvirus medications
Mechanisms of antibiotic resistance
Miscellaneous cell wall synthesis inhibitors
Miscellaneous protein synthesis inhibitors
Neuraminidase inhibitors
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Nucleoside reverse transcriptase inhibitors (NRTIs)
Protease inhibitors
Protein synthesis inhibitors: Aminoglycosides
Protein synthesis inhibitors: Tetracyclines
Antihistamines for allergies
Miscellaneous antifungal medications
Antituberculosis medications
Androgens and antiandrogens
Aromatase inhibitors
Estrogens and antiestrogens
PDE5 inhibitors
Progestins and antiprogestins
Uterine stimulants and relaxants
Acid reducing medications
Antidiarrheals
Laxatives and cathartics
Non-corticosteroid immunosuppressants and immunotherapies
Hyperthyroidism medications
Hypoglycemics: Insulin secretagogues
Hypothyroidism medications
Insulins
Miscellaneous hypoglycemics
Mineralocorticoids and mineralocorticoid antagonists
Sympatholytics: Alpha-2 agonists
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Nonbenzodiazepine anticonvulsants
Atypical antipsychotics
Atypical antidepressants
Typical antipsychotics
Lithium
Monoamine oxidase inhibitors
Selective serotonin reuptake inhibitors
Serotonin and norepinephrine reuptake inhibitors
Anti-parkinson medications
Tricyclic antidepressants
Cholinomimetics: Direct agonists
Cholinomimetics: Indirect agonists (anticholinesterases)
Muscarinic antagonists
Migraine medications
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Antigout medications
Folate (Vitamin B9) deficiency
Vitamin D
Fat-soluble vitamin deficiency and toxicity: Pathology review
Approach to viral exanthems (pediatrics): Clinical sciences
Mumps virus
Measles virus
Rubella virus
Bordetella pertussis (Whooping cough)
Poliovirus

Transcript

Watch video only

On the Endocrinology ward, two individuals came in.

The first one is 55 year old Gregor, who came in complaining about weight loss, heat intolerance, chest pain, palpitations and insomnia.

On the clinical examination, he’s anxious and restless.

He had warm and moist skin, his eyelids were retracted and there was exophthalmos of both eyes and tachycardia.

The other person is 37 year old Josie who migrated to the US from Panama.

She came in with similar symptoms as Gregor but on clinical examination, she also had a goiter.

According to her, she recently had a contrast imaging procedure for a different problem.

TSH and levels of T3 and T4 were taken for both individuals.

Levels of TSH were low, while levels of T3 and T4 were high.

Okay, so both individuals had hyperthyroidism.

First, a bit of physiology.

Normally, the hypothalamus detects low blood levels of thyroid hormones and releases thyrotropin-releasing hormone, or TRH, into the hypophyseal portal system.

The anterior pituitary then releases thyroid-stimulating hormone, also called thyrotropin, or simply TSH.

TSH stimulates the thyroid gland which is a gland located in the neck.

The thyroid gland is made up of thousands of follicles, which are small spheres lined with follicular cells.

Follicular cells convert thyroglobulin, a protein found in follicles, into two iodine-containing hormones, triiodothyronine or T3, and thyroxine or T4.

Once released from the thyroid gland, these hormones enter the blood and bind to circulating plasma proteins.

Only a small amount of T3 and T4 will travel unbound in the blood, and these two hormones get picked up by nearly every cell in the body.

Once inside the cell T­4 is mostly converted into T3, and it can exert its effect. T3 speeds up the cell’s basal metabolic rate.

T3 increases cardiac output, stimulates bone resorption, thinning out the bones, and activates the sympathetic nervous system.

Thyroid hormones are also involved in a number of other things, like controlling sebaceous and sweat gland secretion, hair follicle growth, and regulating proteins and mucopolysaccharide synthesis by skin fibroblasts.

Now hyperthyroidism can happen a few different ways and all of them result in too much thyroid hormone and a hypermetabolic state, where cellular reactions are happening faster than normal.

First, hyperthyroidism can be primary, in which case the thyroid gland is the problem and it’s making too many hormones.

There are a few specific diseases associated only with hyperthyroidism but sometimes diseases like thyroiditis, which damages the thyroid and causes hypothyroidism, can cause stored thyroid hormones to leak out, resulting in an initial period of transient hyperthyroidism.

Then there’s secondary hyperthyroidism, where the problem is increased TSH secretion due to a problem with the pituitary gland, like a rare TSH secreting adenoma.

Now, let’s talk about some of the causes of primary hyperthyroidism.

Graves disease is the most common cause of hyperthyroidism, which can sometimes manifests during periods of stress, like during pregnancy.

This is an autoimmune disorder where B cells produce antibodies against several thyroid proteins.

The most high yield autoantibodies you need to remember is thyroid-stimulating immunoglobulins, which are type G immunoglobulins that produce a type II hypersensitivity reaction.

They bind to the TSH receptor on follicular cells and imitate TSH. This results in growth of the thyroid gland and stimulates the follicular cells to produce excess thyroid hormone.

Now, these autoantibodies can also cause Graves ophthalmopathy.

These antibodies activate the T-cells in the retro-orbital space causing them to secrete cytokines like TNF-alpha and IFN-gamma which increase fibroblast secretion of glycosaminoglycans which ultimately increase muscle swelling, muscle inflammation and increase the number of adipocyte count, leading to exophthalmos, which is anterior bulging of the eyes.

Now, thyroid stimulating immunoglobulins also increase the activity of dermal fibroblasts, resulting in pretibial myxedema, with the classical finding of waxy lesions with non-pitting edema that usually appear first on the lower legs.

Now, there is a gene complex involved in the regulation of the immune response and this is called the human leukocyte antigen system, or HLA system.

Interestingly, individuals with Graves disease often have specific HLA genes such as HLA-DR3 and HLA-B8, which are important clues on your exams.

Histology of the thyroid will show tall and crowded follicular epithelial cells with scalloped colloid.

Another cause is toxic multinodular goiter where one or more follicles starts growing bigger and generating lots of thyroid hormones independently of TSH.

A high yield fact is that In about 60% of the cases, this happens due to mutations in the TSH receptors that inappropriately keeps these follicular cells active.

On histology, this appears as focal patches of hyperfunctioning cells with a lot of colloid inside.

Now, nodules that produce a lot of thyroid hormones are called hot nodules because they show increased activity on radioactive iodine uptake tests. They are rarely malignant.

Another high yield concept is the Jod-Basedow phenomenon, or iodine-induced thyrotoxicosis.

The Jod-Basedow phenomenon is hyperthyroidism that happens shortly after administering iodine, even in the form of iodine IV contrast.

The phenomenon does not affect people with normal thyroid function but will affect individuals that’s iodine deficient and have a goiter, or in people with Graves disease, toxic multinodular goiter, or thyroid adenomas.

The key point is that all these disorders have autonomous thyroid tissue that act independently of TSH regulation, so when there’s extra iodine, it provides more material for thyroid hormone production without negative feedback from decreased TSH.

You can think of the Jod-Basedow phenomenon as the opposite of the Wolff-Chaikoff effect where a large increase in iodine actually leads to temporary decrease in thyroid hormone synthesis.

Regardless of cause, symptoms of hyperthyroidism are similar and remember that with hyperthyroidism, everything goes faster.

Metabolic findings include include heat intolerance, weight loss, and increased sweating, due to increased basal metabolic rate.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Thyrotropin Isoforms: Implications for Thyrotropin Analysis and Clinical Practice" Thyroid (2014)
  4. "The Clinical Significance of Subclinical Thyroid Dysfunction" Endocrine Reviews (2007)
  5. "Hyperthyroidism and other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical Endocrinoloigists" Endocrine Practice (2011)
  6. "Emergency Medicine: A Comprehensive Study Guide, Sixth edition" McGraw-Hill Professional (2003)
  7. "β-Adrenergic blockade for the treatment of hyperthyroidism" The American Journal of Medicine (1992)